Chief Executive Officer
Is this your profile?
Alan Shortall was the Chief Executive Officer of Unilife.
PROVIDING PHARMACEUTICAL COMPANIES WITH MARKET-LEADING WEARABLE INJECTORS
Stephen Allan highlights some of the key reasons Unilife’s customer-centric strategy is helping it establish long-term, commercial relationships with many leading pharmaceutical companies and industry suppliers.
DELIVERING VALUE FOR INJECTABLES: UNMET NEEDS, DEVICE SOLUTIONS & THERAPEUTIC OUTCOMES
Unilife examines why pharmaceutical companies are leveraging innovative delivery systems to enhance and differentiate their injectable products so that they can generate powerful value-based.
SELECTING THE RIGHT WEARABLE INJECTOR TECHNOLOGY AND PARTNER
In this article, Alan Shortall provides a detailed run-down of how Unilife’s wearable devices portfolio meets the numerous requirements that pharma partners and patients demand of such a devices, and explains how this differentiates Unilife’s products from others in the space.
PROVIDING FULL-SERVICE SOLUTIONS FOR INJECTABLE DRUG DELIVERY
Alan Shortall provides an introduction to some significant trends in the pharma industry, such as the use of smart phone apps and the move of injectable medication delivery away from the clinical setting.
CRITERIA FOR SELECTING A WEARABLE INJECTOR TECHNOLOGY AND PARTNER
Alan Shortall provides a detailed account of the significant opportunities that wearable injection devices present pharmaceutical and biotech companies.
This website uses functional cookies (but not advertising cookies). View our
Privacy & Cookies Policy